VC  Solas BioVentures

     Office Locations:

412 Georgia Ave. Suite 201
Chattanooga, TN 37403



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Solas BioVentures is a biotechnology and medical device venture capital fund founded by Casey Hammontree in 2014. Hammontree is currently a partner at Tenth Street Capital. Solas BioVentures focuses on early stage biopharmaceuticals, medical devices, diagnostics, digital health technologies and related opportunities in medicine.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Casey Hammontree Founder
    David Adair MD Managing Partner
    Joshua Eckelberry Associate
    Mark Hackett Co-Founder and Managing Partner
    Michael Hoey PhD General Partner


    Recent Funding Events (trailing 12 months):












    Portfolio companies include:


    Recent News: